Cytoflavin in the Rehabilitation of Post-intensive Care Syndrome in Stroke Survivors

NCT04194229 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-07-19

No results posted yet for this study

Summary

Objective - to assess the effect of Cytoflavin® and its tolerability within the integrated program of rehabilitation of patients who underwent ischemic stroke

Conditions

Sponsors & Collaborators

  • POLYSAN Scientific & Technological Pharmaceutical Company

    lead INDUSTRY

Principal Investigators

  • Andrey Belkin, Prof · Brain Institute Clinic, Yekaterinburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-11
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04194229 on ClinicalTrials.gov